Service de Néphrologie-Dialyse-Transplantation, Université d'Angers, Centre Hospitalier Universitaire (CHU) Angers, Angers, France.
Université d'Angers, Université de Nantes, Centre Hospitalier Universitaire (CHU) d'Angers, Institut National de la Santé Et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Centre de Recherche en Cancérologie et Immunologie Nantes-Angers (CRCI2NA), Structure Fédérative de Recherche Interactions Cellulaires et Applications Thérapeutiques (SFR ICAT), Angers, France.
Front Immunol. 2022 Mar 22;13:834878. doi: 10.3389/fimmu.2022.834878. eCollection 2022.
The "Renal Risk Score" (RRS) and the histopathological classification have been proposed to predict the risk of end-stage kidney disease (ESKD) in ANCA-associated glomerulonephritis (ANCA-GN). Besides, factors associated with kidney function recovery after ANCA-GN onset remain to be more extensively studied. In the present study, we analyzed the value of the RRS and of the histopathological classification for ESKD prediction. Next, we analyzed factors associated with eGFR change within the first 2 years following ANCA-GN diagnosis.
We included patients from the Maine-Anjou ANCA-associated vasculitis registry with at least 6 months of follow-up. The values of ANCA-GN, histopathological classification, and RRS, and the factors associated with eGFR variations between ANCA-GN diagnosis and 2 years of follow-up were assessed.
The predictive values of the histopathological classification and RRS were analyzed in 123 patients. After a median follow-up of 42 months, 33.3% patients developed ESKD. The predictive value of RRS for ESKD was greater than that of the histopathological classification. Determinants of eGFR variation were assessed in 80/123 patients with complete eGFR measurement. The median eGFR increased from ANCA-GN diagnosis to month 6 and stabilized thereafter. The only factor associated with eGFR variation in our study was eGFR at ANCA-GN diagnosis, with higher eGFR at diagnosis being associated with eGFR loss (p<0.001).
The RRS has a better predictive value for ESKD than the histopathological classification. The main determinant of eGFR variation at 2 years was eGFR at ANCA-GN diagnosis. Thus, this study suggests that eGFR recovery is poorly predicted by histological damage at ANCA-GN diagnosis.
“肾脏风险评分”(RRS)和组织病理学分类已被提出用于预测抗中性粒细胞胞浆抗体(ANCA)相关性肾小球肾炎(ANCA-GN)患者发生终末期肾病(ESKD)的风险。此外,与 ANCA-GN 发病后肾功能恢复相关的因素仍需要更广泛地研究。在本研究中,我们分析了 RRS 和组织病理学分类对 ESKD 预测的价值。接下来,我们分析了与 ANCA-GN 诊断后 2 年内 eGFR 变化相关的因素。
我们纳入了缅因州-安茹抗中性粒细胞胞浆抗体相关性血管炎登记处至少随访 6 个月的患者。评估了 ANCA-GN、组织病理学分类、RRS 的值,以及 ANCA-GN 诊断后 2 年内与 eGFR 变化相关的因素。
我们分析了 123 例患者的组织病理学分类和 RRS 的预测值。在中位随访 42 个月后,33.3%的患者发生 ESKD。RRS 预测 ESKD 的价值大于组织病理学分类。在 80/123 例有完整 eGFR 测量的患者中评估了 eGFR 变化的决定因素。从 ANCA-GN 诊断到第 6 个月,eGFR 中位数增加,此后稳定。我们研究中的唯一与 eGFR 变化相关的因素是 ANCA-GN 诊断时的 eGFR,诊断时较高的 eGFR 与 eGFR 损失相关(p<0.001)。
RRS 对 ESKD 的预测价值优于组织病理学分类。eGFR 在 2 年内变化的主要决定因素是 ANCA-GN 诊断时的 eGFR。因此,本研究表明,组织学损伤在 ANCA-GN 诊断时对 eGFR 恢复的预测不佳。